Oncolytics Biotech ( ($ONCY) ) has shared an update. On October 10, 2025, Oncolytics Biotech Inc. submitted a corporate presentation to the ...

The Strategy lagged a benchmark that was driven by names with the smallest market caps, lowest returns on equity and highest ...

Sarepta Therapeutics is showing signs of recovery, driven by its robust pipeline and recent revenue growth, despite past ...

Members of Congress are increasingly leveraging their inside knowledge of forthcoming policy changes and economic ...

CSPC Pharmaceutical Group ( ($HK:1093) ) has provided an announcement. CSPC Pharmaceutical Group Limited has received approval from the U.S. FDA ...

These pressures demand more resilient, forward-looking sourcing strategies. This article explores practical approaches to safeguarding API quality and availability. Key considerations include rigorous ...

Keeping samples safe, identifiable, and fully traceable is critical in biobanks, compound libraries, and high-density ...

There are a lot of hot sapphic celebs out there, so we'll have to do a thorough investigation to make a decision!

Ratings for Stoke Therapeutics (NASDAQ: STOK) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ...

Algen Biotechnologies partners with AstraZeneca in a $555 million deal to advance AI-driven CRISPR drug discovery and novel ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.